AAAAAA
Results:
1-9
|
Results: 9
Authors:
Chang, TMS
Citation: Tms. Chang, Bioencapsulated hepatocytes for experimental liver support, J HEPATOL, 34(1), 2001, pp. 148-149
Authors:
Chang, TMS
Citation: Tms. Chang, Red blood cell substitutes, BEST P R C, 13(4), 2000, pp. 651-667
Authors:
Prakash, S
Chang, TMS
Citation: S. Prakash et Tms. Chang, In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E-coli DH5 cells, INT J ARTIF, 23(7), 2000, pp. 429-435
Authors:
Chang, TMS
Citation: Tms. Chang, Artificial cell biotechnology for medical applications, BLOOD PURIF, 18(2), 2000, pp. 91-96
Authors:
Chang, TMS
D'Agnillo, F
Yu, WP
Razack, S
Citation: Tms. Chang et al., Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation, ADV DRUG DE, 40(3), 2000, pp. 213-218
Authors:
Chang, TMS
Citation: Tms. Chang, Artificially boosting the blood supply, CHEM IND L, (8), 2000, pp. 281-284
Authors:
Chang, TMS
Citation: Tms. Chang, Future prospects for artificial blood, TRENDS BIOT, 17(2), 1999, pp. 61-67
Authors:
Sarkissian, CN
Shao, ZQ
Blain, F
Peevers, R
Su, HS
Heft, R
Chang, TMS
Scriver, CR
Citation: Cn. Sarkissian et al., A different approach to treatment of phenylketonuria: Phenylalanine degradation with recombinant phenylalanine ammonia lyase, P NAS US, 96(5), 1999, pp. 2339-2344
Authors:
Chang, TMS
Prakash, S
Citation: Tms. Chang et S. Prakash, Removal of urea in uremia and ammonia in liver failure with emphasis on the use of artificial cells for encapsulation of genetically engineered cells, TISS ENG S, 1999, pp. 379-391
Risultati:
1-9
|